Cargando…
SEC14L2 enables pan-genotype HCV replication in cell culture
Since its discovery in 1989, efforts to grow clinical isolates of the hepatitis C virus (HCV) in cell culture have met with limited success. Only the JFH-1 isolate has the capacity to replicate efficiently in cultured hepatoma cells without cell culture-adaptive mutations(1-3). We hypothesized that...
Autores principales: | Saeed, Mohsan, Andreo, Ursula, Chung, Hyo-Young, Espiritu, Christine, Branch, Andrea D., Silva, Jose M., Rice, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632207/ https://www.ncbi.nlm.nih.gov/pubmed/26266980 http://dx.doi.org/10.1038/nature14899 |
Ejemplares similares
-
Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009) -
The Sec14-like phosphatidylinositol transfer proteins Sec14l3/SEC14L2 act as GTPase proteins to mediate Wnt/Ca(2+) signaling
por: Gong, Bo, et al.
Publicado: (2017) -
Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2022) -
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
por: Paolucci, Stefania, et al.
Publicado: (2019) -
A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes
por: Qian, Xi-Jing, et al.
Publicado: (2016)